ATE532787T1 - Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus - Google Patents

Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus

Info

Publication number: ATE532787T1
Authority: AT; Austria
Prior art keywords: treatment; respiratory syncytial; syncytial virus; virus infections; polycyclic
Prior art date: 2006-09-28

Application number

AT07815246T

Other languages

English (en)

Inventor

Jeffrey Peter Mitchell

Alistair George Draffan

Vanessa Anne Sanford

Silas Bond

Chin Yu Lim

Penelope Anne Mayes

Original Assignee

Biota Scient Management

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-28

Filing date

2007-09-26

Publication date

2011-11-15

2007-09-26 Application filed by Biota Scient Management filed Critical Biota Scient Management

2011-11-15 Application granted granted Critical

2011-11-15 Publication of ATE532787T1 publication Critical patent/ATE532787T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Virology (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT07815246T 2006-09-28 2007-09-26 Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus ATE532787T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US84807306P	2006-09-28	2006-09-28
PCT/AU2007/001429 WO2008037011A1 (en)	2006-09-28	2007-09-26	Polycyclic agents for the treatment of respiratory syncytial virus infections

Publications (1)

Publication Number	Publication Date
ATE532787T1 true ATE532787T1 (de)	2011-11-15

Family

ID=39229629

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07815246T ATE532787T1 (de)	2006-09-28	2007-09-26	Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus

Country Status (22)

Country	Link
US (2)	US8598194B2 (de)
EP (1)	EP2069353B1 (de)
JP (1)	JP5340943B2 (de)
KR (1)	KR101488826B1 (de)
CN (1)	CN101583614B (de)
AR (1)	AR063038A1 (de)
AT (1)	ATE532787T1 (de)
AU (1)	AU2007302611C1 (de)
BR (1)	BRPI0717536A2 (de)
CA (1)	CA2664376C (de)
DK (1)	DK2069353T3 (de)
ES (1)	ES2376915T3 (de)
HK (1)	HK1131988A1 (de)
IL (1)	IL197783A (de)
MX (1)	MX2009003336A (de)
NO (1)	NO20091521L (de)
NZ (1)	NZ575805A (de)
PL (1)	PL2069353T3 (de)
PT (1)	PT2069353E (de)
TW (1)	TWI423972B (de)
WO (1)	WO2008037011A1 (de)
ZA (1)	ZA200901983B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1697377B1 (de) *	2003-12-24	2011-01-26	Biota Scientific Management Pty. Ltd.	Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus
TWI423972B (zh)	2006-09-28	2014-01-21	Biota Scient Management	治療呼吸系融合細胞病毒感染之多環劑
TWI508968B (zh) *	2010-02-08	2015-11-21	Biota Scient Management	用於治療呼吸道融合性病毒感染的化合物
US8796303B2 (en) *	2010-11-26	2014-08-05	Biota Scientific Management Pty Ltd.	Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
AU2012292947B2 (en) *	2011-08-05	2017-02-16	Biota Scientific Management Pty Ltd	Compounds for treating respiratory syncytial virus infections
MX2014005197A (es) *	2011-11-04	2014-05-28	Syngenta Participations Ag	Compuestos plaguicidas.
US10118890B2 (en)	2014-10-10	2018-11-06	The Research Foundation For The State University Of New York	Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL137586C (de)	1963-04-11
US3507863A (en) *	1963-12-18	1970-04-21	Sandoz Ag	Isoindolones and method for preparing same
NL126596C (de)	1964-02-11
NL129866C (de)	1965-09-21
CH480350A (de) *	1965-09-21	1969-10-31	Geigy Ag J R	Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen
US3379733A (en) *	1965-12-07	1968-04-23	Sandoz Ag	N-(omega-aminoalkyl)isoindoles and method for preparing same
CH481123A (de)	1966-09-21	1969-11-15	Geigy Ag J R	Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen
DE1670041A1 (de)	1967-03-14	1972-03-02	American Home Prod	Isoindole und Isoindoline
CH482697A (de)	1967-03-17	1969-12-15	Geigy Ag J R	Verfahren zur Herstellung von neuen, kondensierten heterocyclischen Verbindungen
US3885037A (en) *	1968-09-05	1975-05-20	American Home Prod	Method of producing anorexia using imidazolinyl phenyl carbonyl compounds, their acid addition salts and related compounds
US3935218A (en) *	1968-09-05	1976-01-27	American Home Products Corporation	Imidazolinyl phenyl carbonyl compounds acid addition salts and related compounds
US3657221A (en) *	1969-02-19	1972-04-18	American Home Prod	Process for preparing 9b-substituted-1 - sulfonyl - 1 2 3 9b - tetrahydro-5h-imidazo(2 1-a)isoindol-5-ones
US3770766A (en) *	1970-03-10	1973-11-06	American Home Prod	2-(2-amino-2,2-dialkylamino-3-hydroxy-3-phenyl-1h-benz(f)isoindole-1-ones
GB1322339A (en)	1970-03-10	1973-07-04	American Home Prod	Imidazoline derivatives
US3624101A (en) *	1970-03-10	1971-11-30	American Home Prod	2,3-DIHYDRO-5-ARYL-5H-BENZ{8 f{9 IMIDAZO{8 2,1-a{9 ISOINDOL-5-OLS
US3966955A (en) *	1974-08-07	1976-06-29	American Home Products Corporation	Anti-ulcer therapy
US4056536A (en) *	1976-06-29	1977-11-01	Merck & Co., Inc.	Pyrrolo[2,1-b][3]benzazepines
US4701208A (en) *	1983-08-02	1987-10-20	American Cyanamid Company	Dihydroimidazopyrrolopyridine, quinoline, thieno- and furo[2,3-b]pyridine, dihydrothieno- and furo[2,3-b]-pyridine, thieno- and furo[3,2-b]pyridine and dihydrothieno- and furo[3,2-b]pyridine herbicides and method for preparation thereof
DE3520390A1 (de) *	1984-07-07	1986-02-06	Bayer Ag, 5090 Leverkusen	Imidazo-pyrrolo-pyridin-derivate
EP0183993A3 (de)	1984-11-16	1987-12-09	F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft	2H-Imidazo[1',2':1,2]pyrrolo[3,4-b]pyridine und deren Verwendung als Unkrautbekämpfungsmittel
DE3674028D1 (de) *	1985-03-12	1990-10-18	Ciba Geigy Ag	Heterocyclisch kondensierte pyridin-verbindungen als herbizide.
DE3534948A1 (de) *	1985-10-01	1987-04-09	Bayer Ag	Fungizide und wachstumsregulatorische mittel
US4717414A (en) *	1986-08-08	1988-01-05	Ppg Industries, Inc.	Herbicidally active imidazopyrrolo-pyridine (or benzene) derivatives
DE3634952A1 (de) *	1986-10-14	1988-04-21	Bayer Ag	Imidazo-pyrrolo-pyridin-derivate
EP0475908A1 (de) *	1990-09-14	1992-03-18	Ciba-Geigy Ag	Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
DE4103177A1 (de)	1991-02-02	1992-08-06	Boehringer Mannheim Gmbh	Thiazolo-(2,3-a)isoindol-derivate und diese enthaltende arzneimittel
CA2104963A1 (en)	1991-02-28	1992-08-29	Harald Zilch	Use of tricyclic isoindolinones as anti-viral medicaments as well as new optically-active isoindolinones
DE4108395A1 (de)	1991-03-15	1993-01-28	Boehringer Mannheim Gmbh	Verwendung von oxazolo-(2,3-a)isoindol-und imidazo(2,1-a)-isoindol-derivaten als antivirale arzneimittel sowie neue oxazolo(2,3-a)isoindol-derivaten
DE4129779A1 (de) *	1991-09-07	1993-03-11	Boehringer Mannheim Gmbh	Neue tricyclische thiazol- und oxazol-derivate und diese enthaltende arzneimittel
JPH0780886B2 (ja) *	1992-05-15	1995-08-30	ナショナル・サイエンス・カウンシル	三環結合ヒドロキシグアニジン、その製造法及びそれを含む抗癌組成物
AU6729600A (en)	1999-08-25	2001-03-19	Banyu Pharmaceutical Co., Ltd.	Novel isoindole derivatives
CA2347869C (en) *	2000-02-14	2004-01-06	Mobility Electronics, Inc.	Linked bridge
US6489338B2 (en)	2000-06-13	2002-12-03	Bristol-Myers Squibb Company	Imidazopyridine and imidazopyrimidine antiviral agents
JP4058663B2 (ja) *	2000-09-22	2008-03-12	有機合成薬品工業株式会社	リボース１−リン酸類及びヌクレオシド化合物の製造方法
US6506738B1 (en)	2000-09-27	2003-01-14	Bristol-Myers Squibb Company	Benzimidazolone antiviral agents
US20040161846A1 (en)	2000-11-22	2004-08-19	Mason Anthony John	Method of expression and agents identified thereby
WO2002066479A1 (fr)	2001-02-23	2002-08-29	Banyu Pharmaceutical Co.,Ltd.	Derives de l'isoindole
AUPR878401A0 (en)	2001-11-09	2001-12-06	Biota Holdings Ltd	Methods for identifying or screening anti-viral agents
EP1697377B1 (de) *	2003-12-24	2011-01-26	Biota Scientific Management Pty. Ltd.	Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus
LT3284520T (lt)	2005-04-28	2019-09-25	Viiv Healthcare Company	Policiklinis karbamoilpiridono darinys, turintis živ integrazę slopinantį poveikį
TWI423972B (zh)	2006-09-28	2014-01-21	Biota Scient Management	治療呼吸系融合細胞病毒感染之多環劑

2007
- 2007-09-20 TW TW096135090A patent/TWI423972B/zh not_active IP Right Cessation
- 2007-09-26 NZ NZ575805A patent/NZ575805A/en not_active IP Right Cessation
- 2007-09-26 JP JP2009529469A patent/JP5340943B2/ja not_active Expired - Fee Related
- 2007-09-26 EP EP07815246A patent/EP2069353B1/de active Active
- 2007-09-26 PT PT07815246T patent/PT2069353E/pt unknown
- 2007-09-26 BR BRPI0717536-1A patent/BRPI0717536A2/pt not_active IP Right Cessation
- 2007-09-26 ES ES07815246T patent/ES2376915T3/es active Active
- 2007-09-26 WO PCT/AU2007/001429 patent/WO2008037011A1/en active Application Filing
- 2007-09-26 PL PL07815246T patent/PL2069353T3/pl unknown
- 2007-09-26 MX MX2009003336A patent/MX2009003336A/es active IP Right Grant
- 2007-09-26 DK DK07815246.9T patent/DK2069353T3/da active
- 2007-09-26 CA CA2664376A patent/CA2664376C/en not_active Expired - Fee Related
- 2007-09-26 KR KR1020097008619A patent/KR101488826B1/ko not_active IP Right Cessation
- 2007-09-26 CN CN200780042767.9A patent/CN101583614B/zh not_active Expired - Fee Related
- 2007-09-26 AT AT07815246T patent/ATE532787T1/de active
- 2007-09-26 US US12/443,177 patent/US8598194B2/en not_active Expired - Fee Related
- 2007-09-26 AU AU2007302611A patent/AU2007302611C1/en not_active Ceased
- 2007-09-27 AR ARP070104296A patent/AR063038A1/es unknown
2009
- 2009-03-20 ZA ZA200901983A patent/ZA200901983B/xx unknown
- 2009-03-24 IL IL197783A patent/IL197783A/en not_active IP Right Cessation
- 2009-04-17 NO NO20091521A patent/NO20091521L/no not_active Application Discontinuation
- 2009-12-10 HK HK09111555.5A patent/HK1131988A1/xx not_active IP Right Cessation
2013
- 2013-08-30 US US14/015,790 patent/US9675694B2/en active Active

Also Published As

Publication number	Publication date
AR063038A1 (es)	2008-12-23
KR101488826B1 (ko)	2015-02-03
AU2007302611A1 (en)	2008-04-03
RU2009115872A (ru)	2010-11-10
KR20090073212A (ko)	2009-07-02
ES2376915T3 (es)	2012-03-20
IL197783A (en)	2014-01-30
PL2069353T3 (pl)	2012-04-30
DK2069353T3 (da)	2012-02-20
EP2069353A4 (de)	2010-09-15
TW200831505A (en)	2008-08-01
US9675694B2 (en)	2017-06-13
WO2008037011A1 (en)	2008-04-03
BRPI0717536A2 (pt)	2013-10-22
ZA200901983B (en)	2010-03-31
EP2069353B1 (de)	2011-11-09
CA2664376C (en)	2015-06-02
TWI423972B (zh)	2014-01-21
HK1131988A1 (en)	2010-02-12
EP2069353A1 (de)	2009-06-17
AU2007302611B2 (en)	2013-06-20
JP5340943B2 (ja)	2013-11-13
CA2664376A1 (en)	2008-04-03
US8598194B2 (en)	2013-12-03
CN101583614B (zh)	2014-01-22
US20140004111A1 (en)	2014-01-02
NZ575805A (en)	2012-03-30
JP2010504915A (ja)	2010-02-18
MX2009003336A (es)	2009-05-28
CN101583614A (zh)	2009-11-18
NO20091521L (no)	2009-04-21
AU2007302611C1 (en)	2013-11-21
PT2069353E (pt)	2012-02-06
IL197783A0 (en)	2009-12-24
US20100021458A1 (en)	2010-01-28

Publication	Publication Date	Title
ATE541845T1 (de)	2012-02-15	2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
ATE545418T1 (de)	2012-03-15	Zusammensetzungen und kits zur behandlung von influenza
ATE434620T1 (de)	2009-07-15	Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
IL209380A0 (en)	2011-01-31	Small molecule inhibitors for the treatment or prevention of dengue virus infection
ATE527241T1 (de)	2011-10-15	Pyridiazinonderivate zur behandlung von tumoren
ATE429218T1 (de)	2009-05-15	Pinolensäure zur behandlung von übergewicht
DE602005026984D1 (de)	2011-04-28	Chinolin-derivate zur behandlung von latenter tuberkulose
ATE476414T1 (de)	2010-08-15	Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
DE602005017503D1 (de)	2009-12-17	Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ATE521365T1 (de)	2011-09-15	Kinin-antagonisten zur behandlung von blasenfunktionsstörung
ATE532507T1 (de)	2011-11-15	Neramexane zur behandlung von subakuten tinnitus
ATE482939T1 (de)	2010-10-15	Neue antimikrobielle verbindungen, ihre synthese und ihre verwendung zur behandlung von säugetierinfektionen
ATE482709T1 (de)	2010-10-15	Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
ATE534633T1 (de)	2011-12-15	Indazolderivate zur behandlung von hsp90- induzierten krankheiten
ATE533774T1 (de)	2011-12-15	Neuartige nukleosidanaloge zur behandlung von virusinfektionen
ATE532787T1 (de)	2011-11-15	Polycyclische mittel zur behandlung von infektionen mit dem respiratory syncytial virus
DE502006008804D1 (de)	2011-03-10	Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
DE602006003094D1 (de)	2008-11-20	4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DE602006021192D1 (de)	2011-05-19	Visnadin zur Behandlung von Kopfhautjucken
ATE517877T1 (de)	2011-08-15	Neue arzneimittel zur behandlung von atemwegserkrankungen
DE602005016141D1 (de)	2009-10-01	S-mirtazapin zur behandlung von hitzewallungen
BRPI0720323A2 (pt)	2016-08-09	composto, método de tratamento, composição farmacêutica e uso do composto
ATE482707T1 (de)	2010-10-15	1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen
DE602007008759D1 (de)	2010-10-07	Pyrroloä1,2-aüimidazoldion zur behandlung von peripherer neurotoxizität durch chemotherapeutische mittel
DE502005002104D1 (de)	2008-01-10	Hesperidin zur Behandlung von Epilepsie